Navigating the Evolving Landscape of US Healthcare Policy Reforms: Implications for Drug Pricing and Access, Health Equity, and Healthcare Research

Moderator

Elisabeth A Fenwick, PhD, OPEN Health HEOR & Market Access, London, United Kingdom

Speakers

Anton Avanceña, The University of Texas at Austin, Austin, TX, United States; C. Daniel Mullins, PhD, University of Maryland School of Medicine, Baltimore, MD, United States; Grace E Fox, OPEN Health HEOR & Market Access, New York, NY, United States; Julie Patterson, PharmD, PhD, National Pharmaceutical Council, Washington, DC, United States

This educational symposium will explore drug pricing and access under the new US administration, alongside broader implications for health equity and healthcare research. Experts will explore both the short- and long-term effects of these healthcare policy shifts and consider their impact on global markets. The session will offer critical insights into the challenges and opportunities arising from these healthcare policy changes, as well as provide practical guidance on navigating this new era.

Sponsored by Corporate Partner, OPEN Health

Code

050

Topic

Health Policy & Regulatory